- Home
- OABI vs AUDC Comparison
OABI vs AUDC Comparison
Compare OABI & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- AUDC
- Stock Information
- Founded
- OABI 2012
- AUDC 1992
- Country
- OABI United States
- AUDC Israel
- Employees
- OABI N/A
- AUDC N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- AUDC Telecommunications Equipment
- Sector
- OABI Health Care
- AUDC Utilities
- Exchange
- OABI Nasdaq
- AUDC Nasdaq
- Market Cap
- OABI 250.8M
- AUDC 282.4M
- IPO Year
- OABI N/A
- AUDC 1999
- Fundamental
- Price
- OABI $2.06
- AUDC $10.50
- Analyst Decision
- OABI Strong Buy
- AUDC Buy
- Analyst Count
- OABI 3
- AUDC 3
- Target Price
- OABI $7.00
- AUDC $11.67
- AVG Volume (30 Days)
- OABI 545.9K
- AUDC 165.4K
- Earning Date
- OABI 08-06-2025
- AUDC 07-29-2025
- Dividend Yield
- OABI N/A
- AUDC 3.44%
- EPS Growth
- OABI N/A
- AUDC 57.57
- EPS
- OABI N/A
- AUDC 0.56
- Revenue
- OABI $26,744,000.00
- AUDC $242,474,000.00
- Revenue This Year
- OABI N/A
- AUDC $1.54
- Revenue Next Year
- OABI $45.02
- AUDC $1.41
- P/E Ratio
- OABI N/A
- AUDC $18.68
- Revenue Growth
- OABI 27.07
- AUDC N/A
- 52 Week Low
- OABI $1.22
- AUDC $7.70
- 52 Week High
- OABI $4.95
- AUDC $12.72
- Technical
- Relative Strength Index (RSI)
- OABI 59.11
- AUDC 58.07
- Support Level
- OABI $1.90
- AUDC $10.18
- Resistance Level
- OABI $2.19
- AUDC $11.50
- Average True Range (ATR)
- OABI 0.13
- AUDC 0.52
- MACD
- OABI -0.00
- AUDC 0.07
- Stochastic Oscillator
- OABI 40.51
- AUDC 61.69
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.